Market open

Celldex/$CLDX

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Celldex

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.

Ticker

$CLDX
Trading on

Industry

Biotechnology

Employees

160

Celldex Metrics

BasicAdvanced
$1.7B
Market cap
-
P/E ratio
-$2.53
EPS
1.59
Beta
-
Dividend rate
$1.7B
1.59
$53.18
$22.93
1.1M
24.268
23.583
0.217
0.393
-19.73%
-29.84%
159.853
2.21
2.29
-9.988
128.55%
-4.15%
7.18%
12.95%

What the Analysts think about Celldex

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Celldex stock.

Celldex Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Celldex Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $CLDX

$

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Celldex stock?

Celldex (CLDX) has a market cap of $1.7B as of December 04, 2024.

What is the P/E ratio for Celldex stock?

The price to earnings (P/E) ratio for Celldex (CLDX) stock is 0 as of December 04, 2024.

Does Celldex stock pay dividends?

No, Celldex (CLDX) stock does not pay dividends to its shareholders as of December 04, 2024.

When is the next Celldex dividend payment date?

Celldex (CLDX) stock does not pay dividends to its shareholders.

What is the beta indicator for Celldex?

Celldex (CLDX) has a beta rating of 1.59. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.